Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status:
Completed
Trial end date:
2019-07-02
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study
conducted in the United States (US) to assess the efficacy of RP-G28 compared to placebo on
symptom reduction related to lactose intolerance.